Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design

Asthma is a chronic inflammatory airway disease. Increase in airway inflammation is hypothesised to contribute to worsening of asthma symptoms and deterioration in lung function, resulting in the use of reliever medication. Short-acting β(2)-agonists only treat the symptoms, whereas an anti-inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Tim, Pavord, Ian D., Chalmers, James D., Whelan, Glenn, Fagerås, Malin, Rutgersson, Annika, Belton, Laura, Siddiqui, Shahid, Gustafson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276524/
https://www.ncbi.nlm.nih.gov/pubmed/32550224
http://dx.doi.org/10.1183/23120541.00333-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276524/
https://www.ncbi.nlm.nih.gov/pubmed/32550224
http://dx.doi.org/10.1183/23120541.00333-2019

Ejemplares similares